Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18BRISTOL-MYERS SQUIBB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8900566

Drug Substance Claim :

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1725

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8900566

Drug Substance Claim :

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1725

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8900566

Drug Substance Claim :

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8642025

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-11

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 9421192

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1725

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 9421192

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 9421192

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206843

Patent Use Code : U-1725

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-08

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8642025

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2027-08-11

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8629171

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2031-06-13

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

US Patent Number : 8629171

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206843

Patent Use Code : U-1724

Delist Requested :

Patent Use Description : METHOD OF INHIBITING H...

Patent Expiration Date : 2031-06-13

blank